Status:

COMPLETED

Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia

Lead Sponsor:

University Hospital Ostrava

Collaborating Sponsors:

Ministry of Health, Czech Republic

Regional Council of the Moravian-Silesian region, KU MSK

Conditions:

Critical Lower Limb Ischemia

Type-2 Diabetes Mellitus

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

The aim of the presented clinical trial is to evaluate a hypothesis, that BMAC prepared from bone marrow aspirate and injected intramuscularly into ischemic areas of the lower extremity in patients wi...

Detailed Description

Secondary hypothesis assumes, that the intravenous application of BMAC in patients with T2DM older than 30 years of age, with a dose of insulin exceeding 0.7 U/kg/day or 50U/day will result in decreas...

Eligibility Criteria

Inclusion

  • type 2 diabetes mellitus
  • diagnosis of critical limb ischemia
  • non-healing defect on the study limb
  • ABI value \< 50 mmHg or ABI\< 0.4
  • TBI value \< 40 mmHg or TBI \< 0.4
  • TcPO2 \< 20 mmHg in supine position
  • no other suitable surgical or re-vascularization procedure
  • age \> 18 years
  • signed Informed Consent

Exclusion

  • non-signing of the Informed Consent
  • anticipated life expectancy \< 6 months
  • history of bone-marrow disease
  • renal failure or dialysis dependency
  • known malignant disease
  • health risks excluding the possibility of general anaesthesia or sedation
  • life-threatening ischaemic heart disease
  • vast necrosis of the index limb
  • active infectious disease, or ATB treatment
  • treatment with immunosupressives
  • pregnancy, breastfeeding

Key Trial Info

Start Date :

September 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT01818310

Start Date

September 1 2012

End Date

October 1 2018

Last Update

September 30 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital Ostrava

Ostrava, Czechia, 708 52

Safety and Efficacy Study of Autologous Bone Marrow Aspirate Concentrate for No-Option Critical Limb Ischemia | DecenTrialz